C-Path is proud to be part of UNITE4TB, a public-private partnership funded by the Innovative Medicines Initiative and part of the AMR Accelerator.
A new dawn in the fight against Tuberculosis
UNITE4TB, the largest public-private collaboration in tuberculosis drug development, announces start of clinical trials
8 November 2023. Today, UNITE4TB, an international public-private partnership striving to fast- track the development of innovative Tuberculosis (TB) treatments, announced the start of its phase 2B/C clinical trial program with the first participant enrolled at its trial site in Cape Town, South Africa. The announcement is a major milestone for the project and the TB community as a whole, helping to advance TB science and enhance the efficiency with which new treatments are delivered.
Full press release, click here.
